Blueprint Medicines (United States)

233 papers and 14.7k indexed citations i.

About

In recent decades, authors affiliated with Blueprint Medicines (United States) have published 233 papers, which have received a total of 14.7k indexed citations. Scholars at this organization have produced 78 papers in Pulmonary and Respiratory Medicine, 52 papers in Immunology and 51 papers in Oncology on the topics of Lung Cancer Treatments and Mutations (44 papers), Mast cells and histamine (42 papers) and Gastrointestinal Tumor Research and Treatment (24 papers). Their work is cited by papers focused on Molecular Biology (9.0k citations), Oncology (4.3k citations) and Pulmonary and Respiratory Medicine (3.9k citations). Authors at Blueprint Medicines (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Journal of Clinical Investigation, Nature Medicine and Nature Communications. Some of Blueprint Medicines (United States)'s most productive authors include Christoph Lengauer, Erica Evans, Giuseppe Curigliano, Vivek Subbiah and Christopher D. Turner.

In The Last Decade

Fields of papers published by authors at Blueprint Medicines (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Blueprint Medicines (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Blueprint Medicines (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Blueprint Medicines (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Blueprint Medicines (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blueprint Medicines (United States) more than expected).

Rankless by CCL
2025